← FDA Drug Approvals (Drugs@FDA)

POMALIDOMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2022-05-04

Drug application

FDA Application #

ANDA209956

Application type

Abbreviated New Drug Application (Generic)

Brand name

POMALIDOMIDE

Generic name

POMALIDOMIDE

Active ingredients

POMALIDOMIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

Manufacturer

Teva Pharmaceuticals, Inc.

First approval

2022-05-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown